PRINCIPAL INVESTIGATOR/PROGRAM DIRECTOR (Last, Frrst, middte__ King, Michael P. 214-76-1903

 

 

 

 

@ BIOGRAPHICAL SKETCH
Give the folowing information for the key personnel and consultants and collaborators, Begin with the Drincipal ~
investigator/progeam director, Photocopy this Page for each person, ome
NAME 'POSTTION TITLE
Yasuyuki Tokunaga, M.D. | Postdoctoral Research Fellow
|
EDUCATION {Begin with baccalgureate or other initial professional education, such ag nwsing, and include bortdoctoral trainin, A _ :
i t YEAR t
- 7 ND Ni |__DEGREE | | CONFERRED KE P
Yamaguchi University School of Medicine, (MD. | 1986 1 Medicine
Yamaguchi, Japan ! t !
! Lb |

 

RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with Present position, list, in chronologicat order, previous employment,
experience, and honors, Key personne! include the principal investigator and any other individuals who Participate in the scientific
Gevelopment or execution of the project. Key personnel typically will include ail individuals with doctoral or othee professional degrees, but
in some projects will include individuals at the masters or baccalaureate level provided they contribute in a Substantive Way to the scicntific

Employment:
Junior Resident, Depariment of Pediatrics and Child Health, Kurume University, Fukuoka, Japan, 1987-
1989,
Senior Resident, Department of Pediatrics and Child Health, Kurume University, Fukuoka, Japan, 1989-
1993

e Postdoctoral Research Fellow, Department of Neurology, Columbia University, New York, NY, 1994.

present.

Professional Organizations

Japanese Society of Pediatrics
Japanese Society of Inherited Metabolic Disease

Publications

Katafuchi, Y_, Fukuda, T., Maruoka, T., Tokunaga, Y., Yamashita, Y. and Matsuishi, T. (1992). Partial
trisomy 6p with agencsis of the corpus callosum and choanal atresia. J. Child Neurology 7, 114-116,
Tokunaga, Y., Yoshida, 1., Endo, F, and Kato, H. ( 1993). The effect of furosemide on a Patient with

â€œoN
9
co
5
8
w
<
9
wn
=
cL
fh
nt
2
3
5
Re
p
a
z
3
8
F
a4
ne
3
=
5
5
=
2
a

Kato, H. (1993), Diuretic
therapy in a Paticnt with type I pseudohypoaldosteronism, Develop. Pharm. Th Tap., submitted,

Y., Kamazono, S., Nakashima, E., Nishiyari, A., Marita, J., Koga, Y., Yoshida, I.,
Yoshino, M. and Kato, H. (1 993). Mitochondrial respiratory chain defect as 4 possible cause of liver
dysfunction during infancy. J. Pediatrics, submitted.

oo
|
o
=
Cc
S
vo
&

 

 

wo 40035380